Delbert Gail Robinson MD

Professor, Molecular Medicine & Psychiatry, Hofstra Northwell School of Medicine. Associate Professor, The Center for Psychiatric Neuroscience, The Feinstein Institute for Medical Research.

Join to View Full Profile

75-59 263rd StreetGlen Oaks, NY 11004
Phone+1 718-470-8195
Fax+1 718-343-1659

Education & Training

UPMC Medical EducationResidency, Psychiatry, 1980 - 1983
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalInternship, Transitional Year, 1979 - 1980
University of Tennessee Health Science Center College of MedicineClass of 1979

Certifications & Licensure

NY State Medical License 1983 - 2025
PA State Medical License 1980 - 1990
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Treatment for First-Episode Schizophrenia Start of enrollment: 1998 Sep 01
Completed
Phase 4
Optimizing Response in Psychosis Study Start of enrollment: 2006 Apr 01
Terminated
Phase 4
Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis Start of enrollment: 2005 Dec 01
Completed
Phase 4
Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers Start of enrollment: 2006 Apr 01
Completed
Not Applicable
Omega-3 Dietary Supplements in Schizophrenia Start of enrollment: 2013 May 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

The problem of missing data for learning health systems focused on first-episode psychosis.
Delbert G Robinson, Nina R Schooler, Majnu John, John Daniel Cahill, Cristina Gomes Gonzalez
Schizophrenia Research. 2025-04-01
Cerebellar-Cortical Connectivity and Prediction of Antipsychotic Treatment Response in First-Episode Psychosis.
Halil Aziz Velioglu, Julie Moehringer, Todd Lencz, Juan A Gallego, John Cholewa
Schizophrenia Bulletin. 2025-03-10
The COMPASS scale for the assessment of individuals with first episode psychotic disorders.
Delbert G Robinson, Majnu John, Alexander L Miller, Nina R Schooler, John M Kane
Schizophrenia Research. 2024-12-01

Journal Articles

Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia
John M Kane, Eric D Achtyes, Delbert G Robinson, JAMA Psychiatry

Authored Content

Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase SchizophreniaJuly 2020
Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase SchizophreniaJuly 2020

Press Mentions

Long-Acting Antipsychotic Treatment in Early SchizophreniaMarch 29th, 2021
Study Finds Need for Improved Schizophrenia CareDecember 4th, 2014
Medications for Patients with First Episode Psychosis May Not Meet GuidelinesDecember 4th, 2014

Grant Support

Early-phase Schizophrenia: Practice-based Research to Improve Treatment Outcomes (ESPRITO)FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH2019–2025
Adherence Unit (Research Methods Core)National Institute Of Mental Health2010–2012
Clinical Trial: Preventing Morbidity In First Episode SchizophreniaNational Center For Research Resources2008–2010
2-Way Pagers To Improve Schizophrenia Medication AdherenceNational Institute Of Mental Health2007–2008
Preventing Morbidity In First Episode SchizophreniaNational Institute Of Mental Health2005–2008
Preventing Morbidity In First Episode SchizophreniaNational Center For Research Resources2006–2007
2-Way Pagers--Improve Schizophrenia Medication AdherenceNational Institute Of Mental Health2006
Preventing Morbidity In First Episode SchizophreniaNational Institute Of Mental Health2002
Core--Clinical Assessment And TrainingNational Institute Of Mental Health2000–2002
Core--Clinical Assessment And Training UnitNational Institute Of Mental Health1997–1999
Brain Morpholgy In Obsessive-Compulsive DisorderNational Institute Of Mental Health1992–1993